InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,067.80
(
1.23%
)
Dow Jones
38,225.86
(
0.85%
)
Brent Oil
83.62
(
0.10%
)
Bitcoin
59,228.72
(
1.70%
)

Replies to post #2710 on Gilead Sciences Inc (GILD)

Replies to #2710 on Gilead Sciences Inc (GILD)

DewDiligence

12/01/17 11:41 AM

#2713 RE: north40000 #2710

ABBV/ENTA's Mavyret will eventually be approved in China, at which time GILD's market share will drop. But I agree with the author that China will become a large market for HCV drugs.